Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 2143-2152

  Chi, Dorcas D J ^a   Merchant, Randall E ^b   Rand, Robert ^c   Conrad, Andrew J ^a   Garrison, Darryl ^a   Turner, Roderick ^d   Morton, Donald L ^c   Hoon, Dave S B ^c  

^a National Genetics Institute   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

^d SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ANTIGEN DETECTION; ARTICLE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; BRAIN; BRAIN NEOPLASMS; GLIOMA; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; ISOMERASES; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; OXIDOREDUCTASES; PROTEINS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030956966     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lallier TE: Cell lineage and cell migration in the neural crest. Ann NY Acad Sci 1991, 615:158-171
2. Junqueira LC, Carneino J, Kelley RO: Basic Histology. Norwalk, CT, Appleton and Lange, 1992, 163 pp
3. Rimoldi D, Romero P, Carrel S: The human melanoma antigen-encoding gene, Mage-1, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993, 54:527-528
4. Seeger RC, Rosenblatt HM, Imai K, Ferrone S: Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res 1981, 41:2714-2717
5. Wikstrand CJ, Bigner DD: Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies, Cancer Res 1982, 42:267-275
6. Azizi E, Friedman J, Pavlotsky F, Iscovich J, Bornstein A, Shafir R, Trau H, Brenner H, Mass D: Familial cutaneous malignant melanoma and tumors of the nervous system. Cancer 1995, 76:1571-1578
7. Soffer D, Lach B, Constantini S: Melanotic cerebral ganglioglioma: evidence for melanogenesis in neoplastic astrocytes. Acta Neuropathol 1992, 83:315-323
8. Haninec P, Vachtenheim J: Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes. Pigment Cell Res 1988, 1:340-343
9. McCloskey JJ, Parker JC Jr, Brooks WH, Blacker HM: Melanin as a component of cerebral gliomas, Cancer 1976, 37:2373-2379
10. Spagnoli GC, Schaefer C, Willimann TE, Kocher T, Amoroso A, Juretic A, Zuber M, Luscher U, Harder F, Heberer M: Peptide-specific CTL in tumor-infittrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100, and tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Int J Cancer 1995, 64:309-315
11. Hoon DS, Yuzuki D, Hayashida M, Morton DL: Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol 1995, 154:730-737
12. Gaugler B, Van den Eynde B, van der Burggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F, Boon T: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994, 179:921-930
13. van der Bruggen, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254: 1643-1647
14. Song Y-H, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N: The role of tyrosinase in autoimmune vitiligo, Lancet 1994, 344:1049-1052
15. Morton DL, Foshag LJ, Hoon DSB, Nizze JA, Wanek LA, Change C, Davtyan DG, Gupta RK, Elashoff R, Irie RF: Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine, Ann Surg 1992, 216:463-482
16. Barth A, Hoon DS, Foshag LJ, Nizze JA, Famatiga E, Okun E, Morton DL: Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response, Cancer Res 1994, 54:3342-3345
17. Hoon DSB, Irie RF: Current status of human melanoma vaccines. Can they control malignant melanoma? BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol 7, 1997, pp 66-84
18. Hoon DSB, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ, Morton DL: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995, 13:2109-2116
19. Doi F, Chi DDJ, Charuworn BB, Conrad AJ, Russell J, Morton DL, Hoon DSB: Detection of β-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma. Int J Cancer 1996, 65:454-459
20. Hoon DSB, Sarantou T, Doi F, Chi DDJ, Kuo C, Conrad AJ, Schmid P, Turner R, Giuliano A: Detection of metastatic breast cancer by β-hCG polymerase chain reaction. Int J Cancer 1996, 69:369-374
21. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994, 12:475-482
22. Anker L, Ohgaki H, Ludeke BI, Herrmann HD, Kleihues P, Westphal M: p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer 1993, 55:982-987
23. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M: Alternations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Cancer 1996, 78:287-293
24. Ritland SR, Ganju V, Jenkins RB: Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes & Cancer 1995, 12:277-282
25. Nordlund JJ, Abdel-Malek ZA, Boissy RE, Rheins LA: Pigment cell biology: an historical review. J Invest Dermatol 1989, 92:53S-60S
26. Kwon BS, Haq AK, Pomerantz SH, Halaban R: Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 1987, 84:7473-7477
27. Del Marmol V, Beermann F: Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett 1996, 381:165-168
28. Vijayasaradhi S, Bouchard B, Houghton AN: The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med 1990, 171:1375-1380
29. Jackson IJ, Chambers DM, Tsukamoto K, Copeland NG, Gilbert DJ, Jenkins NA, Hearing VA: A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 1992, 11:527-535
30. Kwon BS, Chintamaneni C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N, Barton D, Francke U, Kobayashi Y, Kim KK: Amelanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 1991, 88:9228-9232
31. Kwon B: Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J Invest Dermatol 1993, 100:134S-140S
32. Russo V, Traversal C, Verrecchia A, Mottolese M, Natali PG, Bordignon C: Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 1995, 64:216-221
33. Weynants P, Lethe B, Brasseur F, Marchand M, Boon T: Expression of MAGE genes by non-small-cell-lung carcinomas. Int J Cancer 1994, 56:826-829
34. Woodbury RG, Brown JP, Yeh MY, Hellstrom I, Hellstrom KE: Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 1980, 77:2183-2187
35. Brown JP, Woodbury RG, Hart CE, Hellstrom I, Hellstrom KE: Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 1981, 78:539-543
36. Hoon DSB, Ando I, Sviland G, Tsuchida T, Okun E, Morton DL, Irie RF: Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells. Int J Cancer 1989, 43:857-862
37. Tsuchida T, Saxton RE, Morton DL, Irie RF: Ganglio- sides of human melanoma, J Natl Cancer Inst 1987, 78:45-54
38. Mitchell MS, Harel W, Kan-Mitchell J, LeMay LG, Goedegebuure P, Huang XQ, Hofman F, Groshen S: Active specific immunotherapy of melanoma with allogeneic cell lysates. Ann NY Acad Sci 1993, 690:153-166
39. Hersey P: Vaccinia viral lysates in treatment of melanoma, Biological Approaches to Cancer Treatment: Biomodulation, Edited by MS Mitchell. New York, McGraw-Hill, 1993, pp 302-325
40. Maeurer MJ, Storkus WJ, Kirkwood JM, Lotze MT: New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines. Melanoma Res 1996, 6:11-24
41. Sawamura Y, DeTribolet N: Immunotherapy of brain tumors. J Neurosurg 1990, 34:265-278
42. Allan SG, Cornbleet MA: Brain metastases in melanoma. Pigment Cell 1990, 10:36-52
43. Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM: Malignant melanoma brain metastases: review of Roswell Park Memorial Institute experience. Cancer 1984, 53:2550-2552
44. Prota G: Melanins and Melanogenesis. San Diego, Academic Press, 1992, pp 119-133
45. Rabey JM, Hefti F: Neuromelanin synthesis in rat and human substantia nigra. J Neural Transm 1990, 2:1-34
46. Cowen D: The melanoneurons of the human cerebellum (nucleus pigementosus cerebellaris) and homologies in the monkey. J Neuropathol Exp Neurol 1986, 45:205-221
47. Bundy GM, Merchant RE: Lymphocyte trafficking to the central nervous system: a review of anatomic, immunologic, and molecular mechanisms. Neurosurg Q 1996, 6:51-68.
48. Lampson LA, Hickey WF: Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. J Immunol 1986, 136:4054-4062
49. Natali PG, Bigotti A, Nicotra MR, Viora M, Manfredi D, Ferrone S: Distribution of human class I (HLAS-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984, 44: 4679-4687